Uni-Bio Science Group Limited
UNBSF
$0.00
$0.000.00%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 4.87M | 4.88M | 989.90K | 986.80K | 4.31M |
| Total Depreciation and Amortization | 814.50K | 817.00K | 412.80K | 411.50K | 698.80K |
| Total Amortization of Deferred Charges | -- | -- | 257.60K | 256.80K | -- |
| Total Other Non-Cash Items | -1.95M | -1.95M | 2.59M | 2.58M | -1.55M |
| Change in Net Operating Assets | -- | -- | -3.44M | -3.43M | -- |
| Cash from Operations | 3.73M | 3.75M | 813.30K | 810.70K | 3.46M |
| Capital Expenditure | -- | -- | -2.44M | -2.44M | -- |
| Sale of Property, Plant, and Equipment | -- | -- | 8.90K | 8.90K | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 5.55M | 5.57M | -6.07M | -6.05M | -2.29M |
| Cash from Investing | 5.55M | 5.57M | -8.51M | -8.48M | -2.29M |
| Total Debt Issued | -- | -- | 37.77M | 37.77M | -- |
| Total Debt Repaid | -- | -- | -10.86M | -10.86M | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -12.42M | -12.42M | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -14.53M | -14.53M | -13.26M | -13.26M | 12.66M |
| Cash from Financing | -1.86M | -1.87M | 158.20K | 157.70K | 1.62M |
| Foreign Exchange rate Adjustments | -663.90K | -665.90K | 1.81M | 1.81M | -1.21M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 6.76M | 6.78M | -5.72M | -5.70M | 1.58M |